Anacortes Medicaid expenses for non-oral drug administration reach $1,287 in 2024

In 2024, Medicaid providers in Anacortes billed a total of $1,287 for services in the Drugs Administered Other than Oral Method category, based on information from the U.S. Department of Health and Human Services Medicaid Provider Spending database. This amount represents a 16.5% rise from 2023, when billings for these services totaled $1,105.

Medicaid is a public health insurance initiative managed by states and financed jointly by federal and state governments. The program provides coverage for low-income people, seniors, children, and those with disabilities, making it one of the nation’s largest health care payers.

Since Medicaid expenditures are funded by taxpayers, fluctuations in local spending levels highlight how public health resources are distributed within a community.

The “Drugs Administered Other than Oral Method” group includes services classified by specific types of care, determined through standardized HCPCS and CPT code sets. Each code is allocated to a single service category for this report, utilizing uniform code prefixes and ranges to ensure related services are grouped together without duplication and accurate tracking over time.

Although overall Medicaid disbursements rose in several service categories, Drugs Administered Other than Oral Method ranked 11th by total Medicaid billing in Anacortes for 2024.

Across Washington, the Drugs Administered Other than Oral Method category was 10th in payment volume among Medicaid service categories for 2024.

Looking at the five-year span ending in 2024, Medicaid spending on the Drugs Administered Other than Oral Method category in Anacortes climbed by $525, a 29% gain. There were notable year-over-year increases in 2022 and 2021 amid certain periods of accelerated growth.

Spending for this category was recorded throughout Anacortes but was heavily concentrated in select ZIP codes. ZIP code 98221 accounted for all Medicaid payments in this category in 2024, with $1,287 billed. Altogether, the leading ZIP code represented 100% of the city’s Medicaid spending for this service group during the year.

Payments under the Drugs Administered Other than Oral Method category were also clustered within a small subset of the category’s individual billing codes.

Comparatively, Medicaid payments for the Drugs Administered Other than Oral Method category in Anacortes rose 16.5% from 2023 to 2024, against a citywide increase of 11.5% among all Medicaid claim types during the same timeframe.

According to the Centers for Medicare & Medicaid Services, combined federal and state Medicaid spending reached about $871.7 billion in fiscal year 2023, making up approximately 18% of all U.S. health care outlays. This was a sharp increase from roughly $613.5 billion in 2019, prior to the COVID-19 pandemic.

This growth equates to a nearly 40% increase over just a few years, primarily driven by expanded program enrollment and increased service use during and after the pandemic.

Recent federal budget measures under the Trump administration have introduced major proposals intended to reduce federal Medicaid funding and overhaul how the program functions. The “One Big Beautiful Bill Act,” enacted in 2025, is expected to decrease federal Medicaid spending by more than $1 trillion over the next decade, with added policies like work requirements and higher cost-sharing that could curtail access and funding for certain enrollees. These adjustments are expected to increase the financial responsibility of states and restrict the federal Medicaid budget’s growth, while the program continues to serve tens of millions of Americans.

Note: HCPCS codes are shown for context within the category. Category totals and rankings in this article are based on standardized service groupings rather than individual billing codes.

Information in this article was obtained from the U.S. Department of Health and Human Services Medicaid Provider Spending database. The source data can be found here.